Imagine a healthcare system where every individual, regardless of their financial status, has access to essential medicines and diagnostic tests at no cost. This vision is becoming a reality in India, thanks to the government's ambitious ₹3,500 crore initiative under the Medical Access and Assistance (MAA) scheme.
As Union Health Minister JP Nadda stated, "This scheme is a game-changer for the medical device industry and will significantly contribute to making India self-reliant."
A substantial portion of the MAA scheme's budget is dedicated to enhancing diagnostic services. The plan includes increasing the number of free diagnostic tests available at government-run health centers. For instance, in Delhi, the government has already expanded free diagnostic tests in 'mohalla clinics' to 450, benefiting approximately 2 crore residents annually.
Finance Minister Kailash Gahlot emphasized, "We have worked hard to create a robust healthcare model where people can get their treatment done with dignity."
The MAA scheme also focuses on bolstering the domestic medical devices industry. With an allocation of ₹500 crore, the government aims to reduce dependency on imports by promoting local manufacturing. This investment will support the development of essential medical equipment, ensuring that healthcare providers have access to necessary tools without relying on foreign sources.
Rajiv Nath, Forum Coordinator of the Association of Indian Medical Device Industry (AiMeD), expressed optimism, stating, "We are delighted with the announcement... giving impetus to manufacturing of medical devices."
Recognizing the importance of a skilled workforce, the scheme allocates ₹100 crore for capacity building and skill development in the medical devices sector. This investment will fund specialized training programs, ensuring that professionals are equipped to handle advanced medical technologies and contribute effectively to the healthcare system.
To support these initiatives, the government plans to establish common facilities for medical device clusters, with an allocation of ₹110 crore. These facilities will include research and development labs, design and testing centers, and other essential infrastructure to foster innovation and efficiency in the medical devices industry.
(Input from various media sources)
(Rehash/Hardik Rathod/MSM)